The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

To join this study, you need to be at least 18 years old and have been diagnosed with bipolar disorder type 1 or 2, currently experiencing a depressive episode. A key requirement is that your first treatment for this depression hasn't worked as well as hoped, and you and your doctor are open to trying a different treatment approach.

You also need to be experiencing a noticeable level of depressive symptoms and finding it hard to manage everyday activities due to your mood. A doctor will check these symptoms using specific scales. Female participants who could become pregnant must use effective birth control during the study, and male participants taking certain study medications will also need to use contraception.

However, you won't be able to join if you are pregnant or breastfeeding, or if you have known allergies to any of the medications being tested in the study. Similarly, if you have any medical conditions that would make taking these specific medications unsafe, you would not be eligible.

If you decide to take part in this study, you will first have a meeting where you'll sign consent forms and have your diagnosis and symptoms checked. This includes an interview and filling out some questionnaires. If you meet all the criteria, you'll be assigned to one of the treatment groups – either receiving a new, intensified medication plan or continuing with standard care. This will involve taking specific medications, which could include drugs like Escitalopram, Lithium, or Quetiapine, as chosen by the study team based on what's best for you.

Over six weeks, you will have several appointments (around 4-6 visits, some in person, some potentially by phone) where your doctors will monitor your symptoms, how you're feeling, and any side effects. You'll complete questionnaires at these visits to track your progress and wellbeing. The total duration of active treatment in the study is six weeks, after which your care will return to your regular doctor, but you might have some follow-up checks. All information gathered will be kept confidential.